DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Wilcox MH, Gerding DN, Poxton IR. et al.
Bezlotoxumab for prevention of recurrent Clostridium difficile infection.
N Engl J Med 2017;
376: 305-317
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.